Anixa Biosciences Inc

ANIX · XNAS

CIK 715446fmd_1ETC214KBKHR6B7T9QX8ZSY29GManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Nov 01, 2009 to Jul 31, 2026, 65 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.